Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • t-nakaba
    Junior Member
    • Nov 2019
    • 2

    Problem with DRAGEN Bio-IT Platform

    I have a problem with DRAGEN Bio-IT Platform.

    When I ran the map/alin and valiant caller pipeline, it stopped running by time out error.
    I asked to illumina technical support, and changed the usage memory amount using this option.

    " --bin_memory 60000000000 "

    However, this option and more usage memory (200,000,000,000) did not solve the problem, and error was printed as below.

    " The DRAGEN WatchDog service has detected a fault: Available free memory (1518 MB) is below minimum threshold (2048 MB) required by DRAGEN "

    I have enough memory server and I did not run any other scripts at the same when I ran DRAGEN pipeline.
    This probrem was happened when I input 193 Gbyte fastq.gz file.

    Could you tell me how I can solve this problem and/or the cause of this problem?
  • dtownley
    Junior Member
    • Sep 2008
    • 1

    #2
    please send this to Illumina Tech-Support ( [email protected] )

    Comment

    • kds1
      Junior Member
      • Mar 2023
      • 1

      #3
      Hi did you got any solution? I am stuck in the same position and trying to figure out

      Comment

      • t-nakaba
        Junior Member
        • Nov 2019
        • 2

        #4
        It has been a long time and I don't remember exactly, but I think I solved the problem by trimming the polyG at the end of reads.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 12:17 PM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...